Literature DB >> 19490979

Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China.

Zhiqiang Wu1, Fan Yang, Rong Zhao, Lina Zhao, Deyin Guo, Qi Jin.   

Abstract

Enterovirus 71 (EV 71) is one of the commonest causative agents of hand, foot, and mouth disease (HFMD), which infects mainly young children. It has been associated with severe neurological complications worldwide, and has caused significant deaths in many provinces of China from March to May 2008. In this study, RNA interference (RNAi) was used as an antiviral agent to inhibit EV 71 replication in rhabdomyosarcoma (RD) cells. Three small interfering RNAs (siRNAs) targeting extremely conserved regions among multiple EV 71 strains in China could effectively block the replication of EV 71 strain Shzh-98. Combination transfection of these three siRNAs could produce a strong inhibitory effect not only in strain Shzh-98, but also in one epidemic strain Fuyang-0805 isolated from a child in the city of Fuyang with a clinical diagnosis of HFMD in 2008. These strategies and results suggest that RNAi has potential therapeutic use for the suppression of EV 71 infection in a broad spectrum of viral strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490979     DOI: 10.1016/j.jviromet.2009.04.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  Enterovirus 3A Facilitates Viral Replication by Promoting Phosphatidylinositol 4-Kinase IIIβ-ACBD3 Interaction.

Authors:  Xia Xiao; Xiaobo Lei; Zhenzhen Zhang; Yijie Ma; Jianli Qi; Chao Wu; Yan Xiao; Li Li; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Analysis of synonymous codon usage in enterovirus 71.

Authors:  Hua Zhang; Hong-Wei Cao; Feng-Qi Li; Zi-Ye Pan; Zhi-Jun Wu; Yan-Hong Wang; Yu-Dong Cui
Journal:  Virusdisease       Date:  2014-05-21

4.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

5.  COPI is required for enterovirus 71 replication.

Authors:  Jianmin Wang; Zhiqiang Wu; Qi Jin
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model.

Authors:  L Huang; X Liu; J L Li; J L Chang; G C Liu; X F Yu; W Y Zhang
Journal:  Braz J Med Biol Res       Date:  2015-03-27       Impact factor: 2.590

7.  The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs.

Authors:  Jun-Xia Deng; Xiao-Jing Nie; Ying-Feng Lei; Chao-Feng Ma; Dong-Liang Xu; Biao Li; Zhi-Kai Xu; Guo-Cheng Zhang
Journal:  J Biomed Sci       Date:  2012-08-13       Impact factor: 8.410

8.  Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease.

Authors:  Yan Zhang; Haiying Liu; Linghang Wang; Fan Yang; Yongfeng Hu; Xianwen Ren; Guojun Li; Yu Yang; Yang Yu; Shaoxia Sun; Yufen Li; Xinchun Chen; Xingwang Li; Qi Jin
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites.

Authors:  Jianmin Wang; Jiang Du; Zhiqiang Wu; Qi Jin
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

Review 10.  Recent developments in antiviral agents against enterovirus 71 infection.

Authors:  Chee Wah Tan; Jeffrey Kam Fatt Lai; I-Ching Sam; Yoke Fun Chan
Journal:  J Biomed Sci       Date:  2014-02-12       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.